Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial Meeting Abstract
| Authors: | Swisher, E. M.; Coleman, R. L.; Bookman, M. A.; Brady, M. F.; Fleming, G. F.; Friedlander, M.; Cunningham, M. J.; Tewari, K. S.; Edraki, B.; Moxley, K.; Mantia-Smaldone, G. M.; Ratajczak, C.; Dinh, M. H.; Sullivan, D. M.; McClain, S.; Okubo, S.; Steffensen, K. D.; Aghajanian, C. |
| Abstract Title: | Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial |
| Meeting Title: | 51st Annual Meeting of the Society of Gynecologic Oncology (SGO) |
| Journal Title: | Gynecologic Oncology |
| Volume: | 159 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Mar 28-31 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-10-01 |
| Start Page: | 20 |
| End Page: | 21 |
| Language: | English |
| ACCESSION: | WOS:000579556200037 |
| DOI: | 10.1016/j.ygyno.2020.06.040 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 37 -- This meeting was cancelled due to COVID-19 -- Source: Wos |
